ESC Premium Access

SGLT2 inhibitors should be given to all patients with heart failure - Discussion.

Congress Presentation

2 more presentations in this session

SGLT2 inhibitors should be given to all patients with heart failure - PRO.

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

SGLT2 inhibitors should be given to all patients with heart failure - CON.

Speaker: Professor R. De Boer (Rotterdam, NL)

Thumbnail

Access the full session

Controversies in Heart Failure: SGLT2 Inhibitors Should Be Given to All Patients

Speakers: Professor J. McMurray, Professor R. De Boer
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

Introduction.

29 August 2021

ESC Premium Access

Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy? – discussion.

29 August 2021

ESC Premium Access

EMPEROR-Preserved - Discussant review.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk